Maintain and develop commercial forecasts for pipeline assets including assumptions, methodologies, and documentation
Assess forecast risk and uncertainty, run sensitivities analysis and scenarios
Conduct primary and secondary market research to understand disease epidemiology, patient segmentation, treatment paradigm, unmet medical needs, competitive landscape, etc.
Translate insights from market research to both qualitative and quantitative commercial assessment
Support major planning processes such as LRP, portfolio prioritization and strategic planning cycles with forecast submissions, scenarios, and narratives
Coordinate inputs and data from internal sources and external datasets; ensure data quality and consistent use of definitions/assumptions across teams
Support commercial/business case assessment to inform pipeline programs’ go-no-go and critical investment decisions
Collaborate with peers and support cross-functional teams to establish Target Product Profiles and develop market positioning strategies for early-stage pipeline programs
Collaborate with peers and support cross-functional teams to establish relevant Disease Area Strategies

BS with 6+ years or MS with 4+ years or Doctorate with 3+ years in commercial assessment from pharmaceutical industry, consulting, or equity analyst roles
Advanced degree preferred in life sciences, business, finance or related field
Oncology and Immunology & inflammatory disease area knowledge/experience strongly preferred
Demonstrated track-record in indication-, and patient-level forecasting methodologies
Proficient in both primary and secondary market research
Excellent communication skills and strong analytical skills
Experience of working in a cross-functional setting
Ability to work on multiple projects simultaneously and effectively prioritize work
Ability to work in a rapidly changing environment
Excellent learning capability and aspiration for excellence.

Senior Manager, Pipeline & Business Development Valuation

Key skills